[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MY179921A - Infection protection agent - Google Patents

Infection protection agent

Info

Publication number
MY179921A
MY179921A MYPI2015702737A MYPI2015702737A MY179921A MY 179921 A MY179921 A MY 179921A MY PI2015702737 A MYPI2015702737 A MY PI2015702737A MY PI2015702737 A MYPI2015702737 A MY PI2015702737A MY 179921 A MY179921 A MY 179921A
Authority
MY
Malaysia
Prior art keywords
protection agent
infection
infection protection
lactadherin
phylactic agent
Prior art date
Application number
MYPI2015702737A
Inventor
Ken Katoh
Hiroshi Urazono
Tomoki Takahashi
Yuki Mizuno
Koichiro Yoshioka
Toshiya Kobayashi
Original Assignee
Megmilk Snow Brand Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Megmilk Snow Brand Co Ltd filed Critical Megmilk Snow Brand Co Ltd
Publication of MY179921A publication Critical patent/MY179921A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Husbandry (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)

Abstract

Provided is an infection phylactic agent containing, as an active ingredient, lactadherin and/or a product prepared by decomposition of lactadherin with a protease. The infection phylactic agent can be produced from the milk of a mammal by a simple process at low cost, and thus can be safely ingested routinely.
MYPI2015702737A 2013-03-08 2014-03-07 Infection protection agent MY179921A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2013046737A JP6346405B2 (en) 2013-03-08 2013-03-08 Infection preventive

Publications (1)

Publication Number Publication Date
MY179921A true MY179921A (en) 2020-11-19

Family

ID=51491438

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2015702737A MY179921A (en) 2013-03-08 2014-03-07 Infection protection agent

Country Status (8)

Country Link
JP (1) JP6346405B2 (en)
CN (1) CN105025914B (en)
AU (1) AU2014226864B2 (en)
HK (1) HK1210942A1 (en)
MY (1) MY179921A (en)
NZ (1) NZ711985A (en)
TW (1) TWI646969B (en)
WO (1) WO2014136931A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016104642A1 (en) * 2014-12-25 2016-06-30 一般財団法人糧食研究会 Emulsion stabilizer and emulsion stabilization method using same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007026669A1 (en) * 2005-09-02 2007-03-08 Shizuoka Prefectural Universities Corporation Method for determination of recognition specificity of virus for receptor sugar chain
JP2008031156A (en) * 2006-07-07 2008-02-14 National Univ Corp Shizuoka Univ Antiviral agent
US8450441B2 (en) * 2007-06-28 2013-05-28 National University Corporation Shizuoka University Synthetic N-linked sialo-glycan-containing polymer and method for producing the same
EP2389952A1 (en) * 2010-05-31 2011-11-30 Rotalactis Srl Lactadherin-derived peptides as antiviral agents
WO2012149254A2 (en) * 2011-04-28 2012-11-01 The Feinstein Institute For Medical Research Mfg-e8 and uses thereof

Also Published As

Publication number Publication date
NZ711985A (en) 2020-06-26
AU2014226864B2 (en) 2018-09-13
TWI646969B (en) 2019-01-11
CN105025914B (en) 2020-02-18
AU2014226864A1 (en) 2015-09-24
JP2014172862A (en) 2014-09-22
JP6346405B2 (en) 2018-06-20
TW201446257A (en) 2014-12-16
HK1210942A1 (en) 2016-05-13
WO2014136931A1 (en) 2014-09-12
CN105025914A (en) 2015-11-04

Similar Documents

Publication Publication Date Title
MY165759A (en) Pull-on diaper
PH12015501888A1 (en) Novel bacteriophage and antibacterial composition comprising the same
MX2016004945A (en) Processes for the preparation of pesticidal compounds.
JOP20130342B1 (en) A stabilized pemetrexed formulation
WO2013135494A3 (en) Lithographic apparatus
MX359999B (en) Liquid stable bovine virus vaccines.
PH12015501933B1 (en) Novel pyridine derivatives
EP3137145A4 (en) Resuscitation arrangement comprising mask, monitoring arrangements, and digital module detachably arranged as part of the mask
MX2015011837A (en) Co-crystals of pyrimethanil and selected dithiine tetracarboximide.
WO2015058664A8 (en) Use of icaritin in preparing medicament for preventing or treating hematocytopenia
PH12016501865A1 (en) Pyridine-2-amides useful as cb2 agonists
NZ712582A (en) Medical accessory holder
MX2017006709A (en) Agent for preventing or improving symptoms caused by imbalance of sex hormones.
MX2017007577A (en) Dihydropyrimidine-2-one compounds and medicinal uses thereof.
IN2014DN08496A (en)
MX368268B (en) Hiv treatment formulation of atazanavir and cobicistat.
MX351860B (en) Injection closure system.
MX2017006712A (en) Matrix metalloproteinase production inhibitor.
MX363458B (en) Novel tetrazolone derivatives.
MX2016004328A (en) Immunopotentiator.
EA201500942A1 (en) ANTI-VIRUS INDOLO [2,3-b] HINOXALINE
MY179921A (en) Infection protection agent
WO2015073788A3 (en) Methods and compositions for the treatment of hcmv
MX2016011413A (en) Formulations comprising polymeric xyloglucan as a carrier for agriculturally beneficial agents.
WO2015051268A3 (en) Hiv protease inhibitors against picornavirus infection